The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH

Sep 20, 2024

- Sep 19, 2025

1.0

Claim your AMA PRA Category 1 Credit

This course is available for logged in users only. Please login or register to take the course.

Patient Self-Management of Acute PSVT: A Systematic Review of Etripamil Data from AHA25

AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors ...

The Nephrology Community’s Reception of New Phase 3 Data on Aldosterone Synthase Inhibitor...